| Interactions between Xenobiotics and DME (XEOTIC)
|
| Fungicide(s), Herbicide(s) or Insecticide(s) |
| Fungicide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| 2,4,6-trichlorophenol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00962
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Fungicide |
| DME Modulation |
2,4,6-trichlorophenol inhibits the expression of DME HSD17B4 |
[1] |
| Herbicide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Atrazine |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00969
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Herbicide |
| DME Modulation |
Atrazine up-regulates the expression of DME HSD17B4 |
[2] |
| Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Dicrotophos |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01050
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Pesticide/Insecticide |
| DME Modulation |
Dicrotophos inhibits the expression of DME HSD17B4 |
[3] |
| Health or Environmental Toxicant(s) |
| Environmental Pollutant |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| 2-bromophenol |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01121
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Environmental Pollutant |
| DME Modulation |
2-bromophenol up-regulates the expression of DME HSD17B4 |
[4] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Perfluorooctane sulfonic acid |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00921
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health and Environmental Toxicant |
| DME Modulation |
Perfluorooctane sulfonic acid inhibits the expression of DME HSD17B4 |
[1] |
| Lead |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01505
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Lead inhibits the expression of DME HSD17B4 |
[5] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 7 Xenobiotics
|
| Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Acetaminophen inhibits the expression of DME HSD17B4 |
[6], [7] |
| Aminoglutethimide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00233
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Aminoglutethimide inhibits the expression of DME HSD17B4 |
[8] |
| Arsenic trioxide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Arsenic trioxide induces the drug-metabolizing activity of DME HSD17B4 |
[9] |
| Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Copper sulfate inhibits the expression of DME HSD17B4 |
[10] |
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME HSD17B4 |
[11], [12] |
| Fenofibrate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00035
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Fenofibrate up-regulates the expression of DME HSD17B4 |
[13] |
| Ketoconazole |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00251
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Ketoconazole up-regulates the expression of DME HSD17B4 |
[8] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Colforsin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00606
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Colforsin up-regulates the expression of DME HSD17B4 |
[8], [14] |
| Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Quercetin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00538
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Quercetin inhibits the expression of DME HSD17B4 |
[15] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| ICG-001 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01336
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
ICG-001 inhibits the expression of DME HSD17B4 |
[16] |
|
|
|
|
|
|